DEXCOM INC

NASDAQ: DXCM (DexCom, Inc.)

Last update: 3 days ago, 10:25AM

69.09

1.74 (2.58%)

Previous Close 67.35
Open 68.16
Volume 1,373,968
Avg. Volume (3M) 5,659,537
Market Cap 26,659,962,880
Price / Earnings (TTM) 29.65
Price / Earnings (Forward) 27.40
Price / Sales 5.85
Price / Book 9.15
52 Weeks Range
54.11 (-21%) — 89.98 (30%)
Earnings Date 29 Jul 2026
Profit Margin 12.90%
Operating Margin (TTM) 12.91%
Diluted EPS (TTM) 1.33
Quarterly Revenue Growth (YOY) 12.50%
Quarterly Earnings Growth (YOY) -28.00%
Total Debt/Equity (MRQ) 113.97%
Current Ratio (MRQ) 1.50
Operating Cash Flow (TTM) 964.10 M
Levered Free Cash Flow (TTM) 509.04 M
Return on Assets (TTM) 5.97%
Return on Equity (TTM) 23.72%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Bearish Mixed
Medical Devices (Global) Mixed Mixed
Stock DexCom, Inc. Mixed Bearish

AIStockmoo Score

-1.8
Analyst Consensus -2.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages -2.5
Technical Oscillators -0.5
Average -1.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
DXCM 27 B - 29.65 9.15
PODD 11 B - 37.33 8.18
SSII 741 M - - 12.96
GEHC 30 B 0.21% 15.80 2.77
IRTC 4 B - - 24.17
ESTA 3 B - - 170.83

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Sector Healthcare
Industry Medical Devices
Investment Style Mid Growth
% Held by Insiders 0.42%
% Held by Institutions 97.10%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria